| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
LFMD
LifeMD
|
Aug 07, 2026 | BUY |
Strong Buy
+210.3% avg upside
14 analysts
|
$5.00
51.91% Upside
|
-5.1% | · |
|
SDGR
Schrodinger
|
Aug 06, 2026 | BUY |
Strong Buy
+52.1% avg upside
14 analysts
|
$20.00
7.44% Upside
|
+3.9% | · |
|
ELAN
Elanco Animal Health
|
Aug 06, 2026 | BUY |
Strong Buy
+41.9% avg upside
18 analysts
|
$30.00
35.47% Upside
|
-7.4% | · |
|
WAY
Waystar Holding Corp.
|
Jul 31, 2026 | BUY |
Strong Buy
+51.7% avg upside
30 analysts
|
$30.00
22.15% Upside
|
+14.8% | · |
|
OMCL
Omnicell
|
Jul 31, 2026 | BUY |
Strong Buy
+32.0% avg upside
12 analysts
|
$65.00
74.97% Upside
|
+4.9% | · |
|
PGNY
Progyny
|
Jul 13, 2026 | BUY |
Strong Buy
+28.2% avg upside
14 analysts
|
$35.00
37.72% Upside
|
-20.5% | · |
|
HNGE
Hinge Health, Inc. Class A
|
Jul 13, 2026 | BUY |
Strong Buy
+9.7% avg upside
17 analysts
|
$125.00
44.73% Upside
|
-3.1% | · |
|
ODD
ODDITY Tech Ltd. Class A
|
Jun 02, 2026 | HOLD |
Sell
+29.0% avg upside
12 analysts
|
— | +25.7% | · |
|
HQY
Healthequity
|
May 26, 2026 | BUY |
Strong Buy
+7.9% avg upside
20 analysts
|
$125.00
18.58% Upside
|
+21.1% | · |
|
DOCS
Doximity
|
May 14, 2026 | HOLD |
Buy
+37.3% avg upside
28 analysts
|
— | +38.8% | · |
|
ZTS
Zoetis
|
May 08, 2026 | HOLD |
Buy
+62.6% avg upside
23 analysts
|
— | -10.0% | · |
|
PHR
Phreesia
|
Apr 13, 2026 | BUY |
Strong Buy
+39.3% avg upside
21 analysts
|
$12.00
2.18% Downside
|
+43.2% | · |
|
CERT
Certara
|
Apr 13, 2026 | BUY |
Buy
+63.3% avg upside
22 analysts
|
$8.00
0.17% Downside
|
+38.0% | · |
|
TALK
Talkspace
|
Mar 10, 2026 | HOLD |
Buy
-13.6% avg upside
12 analysts
|
— | +1.0% | · |
|
TDOC
Teladoc
|
Feb 27, 2026 | HOLD |
Buy
+330.2% avg upside
38 analysts
|
— | +31.0% | · |
|
ALIT
Alight
|
Feb 19, 2026 | HOLD |
Buy
+57.9% avg upside
10 analysts
|
— | -14.2% | · |
|
HCAT
Health Catalyst
|
Jan 08, 2026 | HOLD |
Buy
+213.2% avg upside
15 analysts
|
— | -27.4% | · |
|
GDRX
GoodRx Holdings
|
Jan 08, 2026 | HOLD |
Buy
+255.4% avg upside
28 analysts
|
— | +31.2% | · |
|
VEEV
Veeva Systems
|
Dec 12, 2025 | HOLD |
Buy
+0.0% avg upside
37 analysts
|
— | +7.3% | · |
|
SLP
Simulations Plus
|
Oct 29, 2025 | HOLD |
Buy
+106.8% avg upside
11 analysts
|
— | +3.0% | · |
|
ABSI
AbSci
|
Apr 16, 2025 | BUY |
Strong Buy
+28.1% avg upside
18 analysts
|
$9.00
5.21% Downside
|
+5.9% | · |
|
ABCL
AbCellera Biologics
|
Apr 16, 2025 | BUY |
Strong Buy
+60.1% avg upside
15 analysts
|
$5.00
51.70% Downside
|
+60.2% | · |
|
LFST
Lifestance Health Group
|
Apr 08, 2025 | BUY |
Strong Buy
-5.5% avg upside
15 analysts
|
$9.00
26.50% Downside
|
+0.1% | · |
|
RXRX
Recursion Pharmaceuticals
|
Jan 08, 2025 | BUY |
Buy
+141.0% avg upside
12 analysts
|
$10.00
203.88% Upside
|
-35.3% | · |
|
MDRX
Veradigm
|
Sep 15, 2022 | HOLD |
Buy
+197.2% avg upside
22 analysts
|
— | -26.8% | · |
|
IQV
IQVIA Holdings
|
Apr 16, 2021 | BUY |
Strong Buy
+1.4% avg upside
39 analysts
|
$250.00
3.42% Upside
|
+10.6% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.